Skip to content

Advertisement

  • Research Article
  • Open Access
  • Open Peer Review

This article has Open Peer Review reports available.

How does Open Peer Review work?

Implementing the EffTox dose-finding design in the Matchpoint trial

BMC Medical Research MethodologyBMC series – open, inclusive and trusted201717:112

https://doi.org/10.1186/s12874-017-0381-x

Received: 3 February 2017

Accepted: 30 June 2017

Published: 20 July 2017

Back to article

Open Peer Review reports

Pre-publication versions of this article are available by contacting info@biomedcentral.com.

Original Submission
3 Feb 2017 Submitted Original manuscript
1 Mar 2017 Reviewed Reviewer Report - Peter Thall
1 May 2017 Reviewed Reviewer Report - Emily Dressler
1 Jun 2017 Author responded Author comments - Kristian Brock
Resubmission - Version 2
1 Jun 2017 Submitted Manuscript version 2
11 Jun 2017 Author responded Author comments - Kristian Brock
Resubmission - Version 3
11 Jun 2017 Submitted Manuscript version 3
Publishing
30 Jun 2017 Editorially accepted
20 Jul 2017 Article published 10.1186/s12874-017-0381-x

How does Open Peer Review work?

Open peer review is a system where authors know who the reviewers are, and the reviewers know who the authors are. If the manuscript is accepted, the named reviewer reports are published alongside the article. Pre-publication versions of the article are available by contacting info@biomedcentral.com.

You can find further information about the peer review system here.

Authors’ Affiliations

(1)
Cancer Research UK Clinical Trials Unit, Institute of Cancer & Genomic Sciences, University of Birmingham, Birmingham, UK
(2)
Paul O’Gorman Leukaemia Research Centre, University of Glasgow, Glasgow, UK

Advertisement